Douglas O. Sobel

1.4k total citations
44 papers, 1.1k citations indexed

About

Douglas O. Sobel is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Douglas O. Sobel has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Genetics and 13 papers in Surgery. Recurrent topics in Douglas O. Sobel's work include Diabetes and associated disorders (14 papers), Immune Cell Function and Interaction (12 papers) and Pancreatic function and diabetes (12 papers). Douglas O. Sobel is often cited by papers focused on Diabetes and associated disorders (14 papers), Immune Cell Function and Interaction (12 papers) and Pancreatic function and diabetes (12 papers). Douglas O. Sobel collaborates with scholars based in United States and Canada. Douglas O. Sobel's co-authors include Ronald J. Iannotti, Tonja R. Nansel, Stefan Schneider, Denise L. Haynie, Bruce G. Simons‐Morton, Leslie Plotnick, Loretta M. Clark, Joseph A. Bellanti, Anthony H. Vagnucci and C. Ewel and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

Douglas O. Sobel

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas O. Sobel United States 17 507 310 290 203 159 44 1.1k
Jill D. Jacobson United States 17 210 0.4× 209 0.7× 199 0.7× 206 1.0× 8 0.1× 42 893
Kerstin Hagenfeldt Sweden 26 888 1.8× 390 1.3× 315 1.1× 98 0.5× 12 0.1× 82 2.3k
J. Wasserman Sweden 22 77 0.2× 162 0.5× 351 1.2× 50 0.2× 7 0.0× 78 1.5k
C. Gottlieb Sweden 21 326 0.6× 126 0.4× 52 0.2× 105 0.5× 10 0.1× 45 1.3k
Raphael David United States 21 511 1.0× 170 0.5× 26 0.1× 167 0.8× 6 0.0× 52 1.2k
Helge Binder Germany 21 208 0.4× 95 0.3× 83 0.3× 95 0.5× 11 0.1× 59 1.2k
Heather L. Burrows United States 15 193 0.4× 116 0.4× 23 0.1× 138 0.7× 9 0.1× 46 953
Mary Gallagher United States 13 300 0.6× 240 0.8× 80 0.3× 100 0.5× 74 0.5× 57 707
C. Wood Australia 20 71 0.1× 91 0.3× 117 0.4× 148 0.7× 13 0.1× 66 2.0k
Ravikumar Balasubramanian United States 21 246 0.5× 423 1.4× 41 0.1× 148 0.7× 8 0.1× 58 1.5k

Countries citing papers authored by Douglas O. Sobel

Since Specialization
Citations

This map shows the geographic impact of Douglas O. Sobel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas O. Sobel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas O. Sobel more than expected).

Fields of papers citing papers by Douglas O. Sobel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas O. Sobel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas O. Sobel. The network helps show where Douglas O. Sobel may publish in the future.

Co-authorship network of co-authors of Douglas O. Sobel

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas O. Sobel. A scholar is included among the top collaborators of Douglas O. Sobel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas O. Sobel. Douglas O. Sobel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sobel, Douglas O., et al.. (2015). The Role of Type I Interferon Subtypes and Interferon-Gamma in Type I Interferon Diabetes Inhibitory Activity in the NOD Mouse. Journal of Interferon & Cytokine Research. 36(4). 238–246. 2 indexed citations
3.
Sobel, Douglas O., et al.. (2010). Cyclosporin and methotrexate therapy induces remission in type 1 diabetes mellitus. Acta Diabetologica. 47(3). 243–250. 29 indexed citations
4.
Sobel, Douglas O., et al.. (2008). Interferon-tau inhibits the development of diabetes in NOD mice. Autoimmunity. 41(7). 543–553. 13 indexed citations
5.
Schneider, Stefan, Ronald J. Iannotti, Tonja R. Nansel, et al.. (2008). Assessment of an Illness-specific Dimension of Self-esteem in Youths with Type 1 Diabetes. Journal of Pediatric Psychology. 34(3). 283–293. 17 indexed citations
6.
Schneider, Stefan, Ronald J. Iannotti, Tonja R. Nansel, et al.. (2007). Identification of Distinct Self-Management Styles of Adolescents With Type 1 Diabetes. Diabetes Care. 30(5). 1107–1112. 37 indexed citations
7.
Iannotti, Ronald J., Stefan Schneider, Tonja R. Nansel, et al.. (2006). Self-Efficacy, Outcome Expectations, and Diabetes Self-Management in Adolescents with Type 1 Diabetes. Journal of Developmental & Behavioral Pediatrics. 27(2). 98–105. 247 indexed citations
8.
Sobel, Douglas O. & Karen Creswell. (2006). Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus. Autoimmunity. 39(4). 323–332. 8 indexed citations
9.
Sobel, Douglas O., et al.. (2002). Gamma Interferon Paradoxically Inhibits the Development of Diabetes in the NOD Mouse. Journal of Autoimmunity. 19(3). 129–137. 39 indexed citations
10.
Sobel, Douglas O., et al.. (2000). Cyclophosphamide inhibits the development of diabetes in the diabetes-prone BB rat. Diabetologia. 43(8). 986–994. 4 indexed citations
11.
Sobel, Douglas O., Norio Azumi, Karen Creswell, et al.. (1995). The role of NK cell activity in the pathogenesis of poly I:C accelerated and spontaneous diabetes in the diabetes prone BB rat. Journal of Autoimmunity. 8(6). 843–857. 9 indexed citations
12.
Yanovski, Jack A., Douglas O. Sobel, & Val Abbassi. (1994). The Differing Presentation of Insulin-Dependent Diabetes Mellitus in Infants and Children. Clinical Pediatrics. 33(9). 556–560. 4 indexed citations
13.
Sobel, Douglas O., C. Ewel, Barbara J. Zeligs, et al.. (1994). Poly I:C Induction of α-Interferon in the Diabetes-Prone BB and Normal Wistar Rats: Dose-Response Relationships. Diabetes. 43(4). 518–522. 25 indexed citations
14.
Sobel, Douglas O. & Val Abbassi. (1991). Use of Fructosamine Test in Diabetic Children. Diabetes Care. 14(7). 578–583. 8 indexed citations
15.
Sobel, Douglas O.. (1990). Corticotropin Releasing Hormone and Arginine Vasopressin Stimulation of Acth and Substance P in Human Mononuclear Leukocytes. Endocrine Research. 16(2). 283–292. 4 indexed citations
16.
Sobel, Douglas O.. (1988). Characterization of 12–0–Tetradecanoyl-Phorl-13 Acetate Mediated Acth Release. Endocrine Research. 14(2-3). 149–163. 5 indexed citations
17.
Sobel, Douglas O. & K.M. Mohamed Shakir. (1988). Monensin inhibition of corticotropin releasing factor mediated ACTH release. Peptides. 9(5). 1037–1042. 4 indexed citations
18.
Sobel, Douglas O.. (1987). Characterization of PGE2 inhibition of corticotropin releasing factor-mediated ACTH release. Brain Research. 411(1). 102–107. 12 indexed citations
19.
Sobel, Douglas O. & Anthony H. Vagnucci. (1982). Angiotensin II mediated acth release in rat pituitary cell culture. Life Sciences. 30(15). 1281–1286. 71 indexed citations
20.
King, Michael & Douglas O. Sobel. (1975). Sex On The College Campus: Current Attitudes And Behavior.. Journal of College Student Personnel. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jill D. Jacobson Breakdown of academic impact, for papers by Kerstin Hagenfeldt Breakdown of academic impact, for papers by J. Wasserman Breakdown of academic impact, for papers by C. Gottlieb Breakdown of academic impact, for papers by Raphael David Breakdown of academic impact, for papers by Helge Binder Breakdown of academic impact, for papers by Heather L. Burrows Breakdown of academic impact, for papers by Mary Gallagher Breakdown of academic impact, for papers by C. Wood Breakdown of academic impact, for papers by Ravikumar Balasubramanian
Rankless by CCL
2026